Article: Sanofi-Synthelabo to Evaluate the Effectiveness of Medication For Insomnia.

MALVERN, Pa. -- Sleep is essential for good health, mental and emotional functioning, and safety. Although it has been shown that complaints of insomnia are relatively common, there is uncertainty as to the true extent of the condition. Most individuals do not mention this often life-altering problem during routine doctor visits.

Primary insomnia is characterized by difficulty initiating or maintaining sleep, or experiencing sleep that is restless, light, or of poor quality that causes significant distress or impairment in social, occupational, or other important areas of functioning. There are many causes of sleep disturbance, however primary insomnia does not ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!